Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States.
about
Relaxation for perimenopausal and postmenopausal symptomsRelaxation for perimenopausal and postmenopausal symptomsPatient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifeneLow-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause.Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexesReduction in menopause-related symptoms associated with use of a noninvasive neurotechnology for autocalibration of neural oscillations.Efficacy of electroacupuncture for symptoms of menopausal transition: study protocol for a randomized controlled trial.Pilot study of integral yoga for menopausal hot flashesEffects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause.Factors that may influence the experience of hot flushes by healthy middle-aged women.Behavioral weight loss for the management of menopausal hot flashes: a pilot studyDuration of menopausal hot flushes and associated risk factorsPrevalence, incidence, and treatments of Dupuytren's disease in the United States: results from a population-based studyEfficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial.Adiposity and hot flashes in midlife women: a modifying role of age.A Population-Based Study of Peyronie's Disease: Prevalence and Treatment Patterns in the United StatesThe impact of multimorbidity on quality of life among midlife women: findings from a U.S. nationally representative survey.Epidemiology of the symptoms of menopause - an intercontinental review.Risk of long-term hot flashes after natural menopause: evidence from the Penn Ovarian Aging Study cohort.Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial.Effects of a dietary intervention and weight change on vasomotor symptoms in the Women's Health Initiative.Effects of escitalopram on menopause-specific quality of life and pain in healthy menopausal women with hot flashes: a randomized controlled trialDesign and methods of a multi-site, multi-behavioral treatment trial for menopausal symptoms: the MsFLASH experienceProvider attributes associated with hormone therapy prescribing frequency.Menopausal hot flushes revisited.Menopausal hot flush: is it only a nuisance or also a marker of cardiovascular disease risk?Menopausal quality of life: RCT of yoga, exercise, and omega-3 supplements.Menopausal hot flushes and vascular health.Emerging hormonal treatments for menopausal symptoms.Effect and safety of paroxetine for vasomotor symptoms: systematic review and meta-analysis.Measuring hot flash phenomenonology using ambulatory prospective digital diaries.Physiologically assessed hot flashes and endothelial function among midlife women.The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.Treatment of climacteric symptoms with an ammonium succinate-based dietary supplement: a randomized, double-blind, placebo-controlled trial.0.5 vs. 1.0 mg estradiol in combination with drospirenone for the treatment of hot flushes.Menopausal Hot Flashes and Carotid Intima Media Thickness Among Midlife Women.Longitudinal analysis of changes in weight and waist circumference in relation to incident vasomotor symptoms: the Study of Women's Health Across the Nation (SWAN).Hot flush severity during the menopausal transition and early postmenopause: beyond hormones.The Relative Burden of Menopausal and Postmenopausal Symptoms versus Other Major Conditions: A Retrospective Analysis of the Medical Expenditure Panel Survey Data.Factors associated with reporting classic menopausal symptoms differ.
P2860
Q24194834-BE12BF04-2117-4F8B-9009-553690DD0DF1Q24234382-05F7C8C1-F69C-4456-8D75-3FD9E9C8DB37Q26751149-68FB0C84-AFFF-46A5-A1D7-580EA112AADFQ30408993-4227F02C-5A1C-4200-9730-A21DFA089381Q30409045-AFC5E1F9-8161-484B-A20F-2ADEE9BCF4F8Q30409122-A20C1FE7-E5E5-4E92-8A96-B6461FC2F864Q33824646-BFDCF9C4-BD04-423A-8CEA-5B8AC33AFA22Q33946549-6F88416F-F099-4A2A-80C0-31756099B22CQ34243328-1481F3FF-9DDC-48D7-95DB-9F1F47A4DD49Q34249261-C8C62A5B-BABD-4612-A260-7CA2A9C6271AQ34735329-9733A28D-3087-4995-9C4E-FCD234405055Q34893335-BAF54DC9-58FF-4695-A553-36D133516DBAQ34975787-C8F755EE-1E38-4DF9-995E-72847CB26EE0Q35086586-A0462D39-7F95-4C21-9975-127181F75CCAQ35432849-9918EF65-B764-4667-B362-D68F0AEA6AF5Q35450218-95AD2BBF-B306-4637-A388-77CA27B43FB3Q35635303-E2238D6F-5F90-43A7-BD2B-BED1C9A470B1Q35903599-338A85C6-8A82-402B-B7D0-327976D32097Q36071381-8298F636-6C03-4AFF-8B78-C4A585EE2813Q36175723-C0C325C4-BA27-423F-9E14-B6731BA04546Q36191949-B2F587DA-5395-417D-A4D4-FD54123CEEA8Q36819851-C7997736-A242-435A-93E2-015866FA3712Q36896573-44F3AACD-250D-463C-BFB0-C3DA8DB59C4AQ37261100-D2AAAE62-51FB-4A81-9550-6C855091E136Q37342902-A78DD773-5AF3-4E3E-86D4-2513D2AF411AQ37630564-424AF124-14DA-4663-9C4F-EA3480D4EA06Q37685675-5E0F3499-E5D1-4A5A-9E9F-8E95F4C833C3Q37831337-6F80D950-6A57-4FD1-A47E-CB19968EBBA6Q38307019-CBDB4AD6-CAEB-4961-A53D-9128D1FA14CFQ38803432-A3232D39-0C81-40CD-B4F4-3659BD3D5C2CQ38806492-984DF2A5-5CE7-40D0-8325-9454205D88E8Q38842367-6C7020E8-E182-4E01-9349-6858F3DD6283Q38993271-3704DCC8-C9E2-4F5A-AD1D-DFA4FFAC75CBQ39165778-3AD35BF7-92DE-487F-8F67-E2C396AD9B22Q39188908-C1CC2106-59B2-4220-99CE-74BB761C1782Q39196091-B30FBBB5-D88D-4B1D-BBB3-64FCA66F6E54Q39281758-C86FF346-48C3-4EA9-9CA5-81D60A3DF778Q41275781-B64AE604-6785-40E1-A730-82A4299BF7DEQ42026679-F9D9E2A6-A4BB-4754-8304-0F3DA1C0407CQ44212903-76378E57-982D-4BCF-A4F1-CEE88000D076
P2860
Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Frequency and severity of vaso ...... al women in the United States.
@en
Frequency and severity of vaso ...... al women in the United States.
@nl
type
label
Frequency and severity of vaso ...... al women in the United States.
@en
Frequency and severity of vaso ...... al women in the United States.
@nl
prefLabel
Frequency and severity of vaso ...... al women in the United States.
@en
Frequency and severity of vaso ...... al women in the United States.
@nl
P2093
P2860
P1433
P1476
Frequency and severity of vaso ...... al women in the United States.
@en
P2093
A L Granger
D Britt DiBenedetti
K B Levine
L Kalilani
R E Williams
S E Fehnel
P2860
P356
10.1080/13697130701744696
P577
2008-02-01T00:00:00Z